<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04905706</url>
  </required_header>
  <id_info>
    <org_study_id>2020.141</org_study_id>
    <nct_id>NCT04905706</nct_id>
  </id_info>
  <brief_title>3D Laparoscopic Adrenalectomies for Adrenal Tumors</brief_title>
  <official_title>Three-dimensional Laparoscopic Adrenalectomies for Benign and Malignant Adrenal Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main drawbacks of conventional 2D laparoscopy are limited depth perception and loss of&#xD;
      spatial orientation. High-quality 3D laparoscopy systems might improve surgical outcomes for&#xD;
      adrenalectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over recent decades, technological advances such as improved video imaging (high-definition&#xD;
      cameras), better instrumentation for dissection and hemostasis, articulating staplers, and&#xD;
      optimized operating room lighting have added safety, efficacy, and precision to minimally&#xD;
      invasive procedures. However, until recently, laparoscopy required surgeons to operate in a&#xD;
      three-dimensional (3D) space with only two-dimensional (2D) images to guide their movements,&#xD;
      resulting in a lack of depth perception and loss of spatial orientation that increased the&#xD;
      risk of errors, fatigue, operative time, and operating room stress and made the technique&#xD;
      difficult to learn.&#xD;
&#xD;
      High-quality 3D laparoscopy was developed as an alternative to conventional 2D laparoscopy.&#xD;
      Several clinical trials and observational studies have compared surgical outcomes between 2D&#xD;
      and 3D laparoscopic systems; however, few clinical studies have examined the usefulness of 3D&#xD;
      laparoscopy systems for adrenalectomies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Anticipated">December 31, 2033</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2033</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complications rate of 3D laparoscopic adrenalectomy</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Rate of medical and surgical complications within 30 days after surgery using the Dindo-Clavien classification, described as:&#xD;
Grade I = Any deviation from the normal postoperative course. Grade 2 = Requiring pharmacological treatment with drugs other than such allowed for grade I complications.&#xD;
Grade III = Requiring surgical, endoscopic or radiological intervention, not under (Grade IIIa) or under general anesthesia (Grade IIIb) Grade IV = Life-threatening complication with single organ (Grade IVa) or Multiorgan dysfunction (Grade IVb) Grade V = Death of a patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Up to 4 weeks</time_frame>
    <description>Total length of hospital stay will be recorded in days beginning at admission for surgery until discharge (number of days) .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Conversion rate trough 3D laparoscopic adrenalectomy</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Conversion to open surgery (Yes vs No).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative bleeding during 3D laparoscopic adrenalectomy</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Blood loss during surgery (millilitres)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time trough 3D laparoscopic adrenalectomy</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Duration of intervention (minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Routine use of abdominal drainage in 3D laparoscopic adrenalectomy</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Use of abdominal drainage intraoperatively (Yes vs No).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of morbidity between obese and non obese patients operated by 3D laparoscopic system</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>No obese: &lt;30 kg/m2 Obese: ≥30 kg/m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of morbidity in patients with prior abdominal surgery versus non operated by 3D laparoscopic system</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Prior abdominal surgery (Yes vs No).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of morbidity between elderly and young patients operated by 3D laparoscopic system</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Young &lt;65 years, Elderly ≥65 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of morbidity between American Society of Anesthesiologists I+II and III+IV operated by 3D laparoscopic system</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>ASA I A normal healthy patient ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of morbidity between adrenal mass size &lt;6 cm versus ≥6 cm operated by 3D laparoscopic system</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Adrenal mass &lt;6 cm, Adrenal mass ≥6 cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of adrenal mass diagnosis operated by 3D laparoscopic system</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Incidentaloma, Aldosteronoma, Pheochromocytoma, Cushing's Adenoma and malignant adrenal tumors (primary or metastasis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of adrenal mass laterality operated by 3D laparoscopic system</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Right adrenal mass, left adrenal mass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of morbidity between 2D versus 3D laparoscopic system</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Conversion (Yes vs No), operative time (min), bleeding (ml), Clavien-Dindo Classification</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Adrenal Tumor</condition>
  <condition>Adrenalectomy; Status</condition>
  <arm_group>
    <arm_group_label>3D laparoscopic adrenalectomy</arm_group_label>
    <description>Operations are done with an high definition 3D laparoscopic system (Olympus, Tokyo, Japan); all personnel wear polarized glasses to achieve stereoscopic imaging in the operating room. Dissection is realized using a hybrid energy system (Thunderbeat, Olympus Europe Se &amp; Co, Hamburg, Germany).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients (age ≥ 18 years) who underwent a unilateral 3D laparoscopic&#xD;
        adrenalectomy for adrenal masses (benign and malignant tumors) from January 2013 to&#xD;
        December 2033.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All adult patients (age ≥ 18 years)&#xD;
&#xD;
          -  Patients diagnosed with adrenal masses (benign and malignant tumors)&#xD;
&#xD;
          -  Underwent a unilateral 3D laparoscopic adrenalectomy from January 2013 to December&#xD;
             2033.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency surgery.&#xD;
&#xD;
          -  Open adrenalectomy.&#xD;
&#xD;
          -  Bilateral adrenalectomies (open or laparoscopy).&#xD;
&#xD;
          -  Patients who underwent laparoscopic adrenalectomy together with another laparoscopic&#xD;
             surgical procedure in the same intervention.&#xD;
&#xD;
          -  Patients without complete follow-up for at least 30 days after hospital discharge.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>José Ignacio Rodríguez-Hermosa, MD, PhD</last_name>
    <phone>+34 972 94 02 56</phone>
    <email>jirodriguez.girona.ics@gencat.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitari Dr. Josep Trueta de Girona</name>
      <address>
        <city>Girona</city>
        <zip>17007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Ignacio Rodríguez-Hermosa, MD, PhD</last_name>
      <phone>972940256</phone>
      <email>jirodriguez.girona.ics@gencat.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 14, 2021</study_first_submitted>
  <study_first_submitted_qc>May 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Three-dimensional laparoscopy</keyword>
  <keyword>Adrenal tumors</keyword>
  <keyword>3D laparoscopic adrenalectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenal Gland Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

